| Abstract: | Three-dimensional (3D) printing is becoming an increasingly important tool in pharmaceutical technology, as it enables the production of medicines with a high degree of personalization for individual patients. The technology is based on the lay-er-by-layer deposition of material, allowing the formation of pharmaceutical dosage forms with precisely defined geometries, structures, and drug release profiles using various techniques such as extrusion, binder jetting, inkjet printing, and photo-polymerization. Key advantages of 3D printing include personalized dosing, the possibility of combining multiple active pharmaceutical ingredients into a single dosage form, and enhanced control over drug release. The technology also supports the development of advanced drug delivery systems, including implants, gastroretentive systems, and dosage forms for ocu-lar, vaginal, or bladder administration. Despite its significant potential, challenges remain in ensuring quality, production reproducibility, biocompatibility of materials used, and regulatory compliance. Thus, 3D printing in pharmacy represents an important step toward the development of personalized medicine in the future. |
|---|